Accenture's consulting and outsourcing business are set for outstanding growth over the next few years. The stock is off it's high a bit after news of their woes with a project for Britain's National Health Service (NHS): Accenture is going to eat $450 Million dollars on the project. (http://yahoo.reuters.com/stocks/QuoteCompanyNewsArticle.aspx? storyID=urn:newsml:reuters.com: 20060329:MTFH19297_2006-03-29_20-10-33_L29127379 &symbol=ACN.N&rpc=44)
However, don't see this as a sign of things to come. The company is dealing with the NHS problem, and investors should see this as an opportunity to get in on a great performing company. If anything, the problems at NHS have stirred things up within the company to better prepare them to take full advantage of the hot consulting market.
$30.01 (04/23/06)
